BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9340472)

  • 21. A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis.
    Hotta N
    J Diabetes Investig; 2019 Jul; 10(4):906-908. PubMed ID: 31152685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The importance of lactate acidosis as a side effect of biguanide therapy].
    Förster H
    Fortschr Med; 1976 Dec; 94(35-36):2065-71. PubMed ID: 1010516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biguanide-induced lactic acidosis in Finland.
    Korhonen T; Idänpään-Heikkilä J; Aro A
    Eur J Clin Pharmacol; 1979 Jul; 15(6):407-10. PubMed ID: 499289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.
    Berger W
    Horm Metab Res Suppl; 1985; 15():111-5. PubMed ID: 3865878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Semi-automatic determination of blood lactate during hypoglycemic treatment with biguanides].
    Gelo Signorino R; Castellazzi R; Gamba S; Grassi G; Zanno C; Bruni B
    Ann Osp Maria Vittoria Torino; 1979; 22(1-6):18-37. PubMed ID: 122229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of metformin in the treatment of type 2 diabetes mellitus.
    Davidson MB; Peters AL
    Am J Med; 1997 Jan; 102(1):99-110. PubMed ID: 9209206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biguanides in oral antidiabetic therapy: indications and limitations].
    Gregorio F; Filipponi P
    Medicina (Firenze); 1988; 8(3):262-8. PubMed ID: 3231038
    [No Abstract]   [Full Text] [Related]  

  • 28. [Metformin-associated lactic acidosis].
    Orban JC; Ghaddab A; Chatti O; Ichai C
    Ann Fr Anesth Reanim; 2006 Oct; 25(10):1046-52. PubMed ID: 17005358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin.
    Wang DS; Kusuhara H; Kato Y; Jonker JW; Schinkel AH; Sugiyama Y
    Mol Pharmacol; 2003 Apr; 63(4):844-8. PubMed ID: 12644585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic optimisation of oral hypoglycaemic therapy.
    Marchetti P; Giannarelli R; di Carlo A; Navalesi R
    Clin Pharmacokinet; 1991 Oct; 21(4):308-17. PubMed ID: 1760902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Metformin efficacious in poorly controlled diabetes mellitus type 2].
    Stades AM; Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2000 Sep; 144(40):1897-900. PubMed ID: 11045134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of non-insulin-dependent diabetes mellitus with metformin.
    Guthrie R
    J Am Board Fam Pract; 1997; 10(3):213-21. PubMed ID: 9159660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin: a new oral biguanide.
    Campbell RK; White JR; Saulie BA
    Clin Ther; 1996; 18(3):360-71; discussion 359. PubMed ID: 8829014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Still sour about lactic acidosis years later: role of metformin in heart failure.
    Kuan W; Beavers CJ; Guglin ME
    Heart Fail Rev; 2018 May; 23(3):347-353. PubMed ID: 28868582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lactic acidosis--a possible complication in buformin-treated diabetics (author's transl)].
    Deppermann D; Heidland A; Ritz E; Hörl W
    Klin Wochenschr; 1978 Sep; 56(17):843-53. PubMed ID: 713413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [10 cases of lactic acidosis during biguanide therapy (buformin and phenformin)].
    Berger W; Mehnert-Aner S; Mülly K; Heierli C; Ritz R
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1830-4. PubMed ID: 1013709
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.
    Salpeter SR; Greyber E; Pasternak GA; Salpeter EE
    Arch Intern Med; 2003 Nov; 163(21):2594-602. PubMed ID: 14638559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy.
    Setter SM; Iltz JL; Thams J; Campbell RK
    Clin Ther; 2003 Dec; 25(12):2991-3026. PubMed ID: 14749143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.